The key steps for pharma in pivoting from proof-of-concept experimenting to enterprise-scale value.
Ramji Vasudevan
Advertisement
Senior Engineering Leader at Altimetrik
Articles by Ramji Vasudevan
While no company has yet achieved the full promise of AI to radically accelerate time to market, meaningful strides are being made across the drug discovery funnel.
Advertisement
Latest Updated Articles
Turning AI Pilots into Enterprise ValuePublished: September 18th 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
2
What Impact will DTC Programs have on Generic Drug Prices?
3
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
4
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
5
